Endocrine care of transpeople part II. A review of cross‐sex hormonal treatments, outcomes and adverse effects in transwomen

@article{Meriggiola2015EndocrineCO,
  title={Endocrine care of transpeople part II. A review of cross‐sex hormonal treatments, outcomes and adverse effects in transwomen},
  author={M. Meriggiola and Giulia Gava},
  journal={Clinical Endocrinology},
  year={2015},
  volume={83}
}
The treatment of transwomen relies on the combined administration of anti‐androgens or GnRH analogues to suppress androgen production and thereby reduce male phenotypic characteristics together with oestrogens to develop female characteristics. In transwomen, synthetic oestrogens such as ethinyl oestradiol, as well as conjugated equine oestrogens (CEE), should be avoided to minimize thromboembolic risks especially in older transwomen and in those with risk factors. Currently, available short… Expand
Contraception across transgender
Presentation of a meningioma in a transwoman after nine years of cyproterone acetate and estradiol intake: case report and literature review
Scalp Hair Regrowth in Hormone-Treated Transgender Woman
Disease screening and prevention for transgender and gender-diverse adults
Health considerations for transgender women and remaining unknowns: a narrative review
Sexual health, transition-related risk behavior and need for health care among transgender sex workers
...
1
2
...

References

SHOWING 1-10 OF 80 REFERENCES
Long-term evaluation of cross-sex hormone treatment in transsexual persons.
Long-term treatment of transsexuals with cross-sex hormones: extensive personal experience.
...
1
2
3
4
5
...